The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001261303
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
19/08/2026
Date registered
Help: Date registered
20/10/2026
Date last updated
Help: Date last updated
20/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
20/10/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
EQUipping Primary care and the general Public to prevent and reduce chronic pain (EQUiPP): A co-designed community and primary healthcare project to improve chronic pain care in rural Australia.
Scientific title
EQUipping Primary care and the general Public to prevent and reduce chronic pain (EQUiPP): a controlled interrupted time series hybrid type 2 effectiveness-implementation study of a co-designed community and primary care intervention among adults living in rural Australia, evaluating opioid and pregabalin dispensing.
Additional trial identifiers [1] 317918 0
MRFF2032007
Universal Trial Number (UTN)
Trial acronym
EQUiPP
Related trial records

Health condition
Health condition(s) studied:
Chronic non-cancer pain (lasting > 3 months). 342886 0
Condition category
Condition code
Musculoskeletal 338999 338999 0 0
Osteoarthritis
Musculoskeletal 339000 339000 0 0
Other muscular and skeletal disorders
Public Health 339001 339001 0 0
Health promotion/education
Public Health 339002 339002 0 0
Health service research
Anaesthesiology 339833 339833 0 0
Pain management

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
EQUiPP (EQUipping Primary care and the general Public to prevent and reduce chronic pain) is a multicomponent, community-embedded intervention comprising concurrent primary care capacity building and community pain literacy initiatives. The intervention is delivered across seven rural towns within two Australian health networks over approximately 4 years and comprises three integrated workstreams.

The overall study observation period comprises an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up. During the pre-intervention period, routinely collected administrative data are used to establish baseline outcome trends, prior to commencement of EQUiPP intervention activities. During the intervention period, the three workstreams are introduced progressively and overlap, rather than commencing simultaneously, with initial community engagement and readiness activities informing subsequent capacity building, co-design, and campaign implementation. Population-level administrative outcome data are collected throughout the intervention period and continue during the post-intervention period to assess changes in outcomes following intervention delivery.

Workstream 1 (6 months): Interest-holder and community engagement to establish and strengthen partnerships with healthcare providers, local government, community organisations, sporting clubs and other community groups, identifying local implementation opportunities, and build community readiness. Activities include meetings and consultation with local organisations and health services, community and interest-holder forums, regular project communications (e.g., email, online meetings, webinar updates), and engagement through existing local networks and community structures. These activities are used to identify local priorities and implementation opportunities, establish and strengthen partnerships, identify potential local networks, connect intervention activities with existing community infrastructure, and inform implementation and adaptation over time.

Workstream 2 (2 years): Primary care capacity building through the Pain Revolution Local Pain Educator (LPE) Program. The LPE Program is a structured two-year program delivered by Pain Revolution (a not-for-profit initiative supported by Adelaide University). During the first year, participating healthcare professionals complete the Professional Certificate in Pain Science and Education delivered by Adelaide University, covering contemporary pain science, pain science education, behaviour-change communication, and graded reactivation. During the second year, LPEs establish Local Pain Collectives (LPCs) and facilitate five structured knowledge exchange sessions incorporating online learning modules, skills-based activities, and locally relevant case discussions, culminating in a community-facing educational event. Each LPE is supported by an experienced Pain Revolution mentor who provides regular feedback and support for skill development and practical application of the theoretical components of the program.

Workstream 3 (approx. 2 years): Co-design and delivery of the Rethink Pain community campaign. An approximately 6-month co-design phase, conducted concurrently with Workstream 2, involves community members, people with lived experience of chronic pain, healthcare professionals and other interest-holders in developing the campaign content, format and delivery strategies. Co-design was undertaken across the seven intervention communities, primarily through facilitated face-to-face community workshops conducted in two waves between June and July 2025, supplemented by online engagement with project partners and other interest-holders. The co-design process comprised four iterative phases: discovery, interpretation, ideation, and refinement. Prior to campaign delivery, the co-design process is evaluated using mixed methods, guided by selected components of the PROSECO Framework, Max-Neef's Fundamental Human Needs framework and Value Network Analysis (VNA), to examine participant experiences and engagement, contextual influences, fulfilment of fundamental human needs, and the tangible and intangible value created and exchanged through participation.

This is followed by an 18-month campaign implementation period. The first approximately 6 months (Foundational Campaign Exposure) comprise billboards, social media advertising and the campaign website. The subsequent approximately 12 months (Intensified Community Implementation) continue these activities alongside local print and radio media, printed resources, community events and presentations, healthcare and pharmacy settings, workplaces and businesses, and other locally tailored activities supported by Community Engagement Officers (‘Champions’). Champions fulfil a separate implementation role from LPEs, although some individuals may fulfil both roles. Champions support locally embedded implementation of the community-facing campaign, whereas LPEs participate in the healthcare professional capacity-building program. Campaign messages address contemporary understandings of chronic pain, evidence-aligned approaches to pain-management and healthcare seeking, and connect community members with local health services and trained Local Pain Educators.

Intervention delivery is tailored to each participating town while maintaining fidelity to core campaign messages, implementation strategies, and approved campaign materials. Intervention activity, reach, engagement, fidelity, and adaptations are monitored through activity and attendance records and campaign distribution and engagement data; adaptations and their rationale are documented.

Evaluation cohorts: A cross-sectional cohort of approximately 500 adults residing in intervention communities completes a one-off online survey 6–12 months following commencement of the community-facing campaign. A longitudinal cohort of approximately 250 adults living with chronic pain in intervention communities completes online surveys at baseline and 6, 12 and 18 months following campaign rollout. Participants are recruited through social media and radio advertising, professional and community networks, partner organisations and local interest-holders, and complete electronic eligibility screening and informed consent.

The evaluation cohorts and population-level administrative data represent separate data-collection components. Population-level administrative outcomes are derived from routinely collected, aggregated data relating to adults aged 18 years and over residing within the intervention and comparator regions; individuals are not specifically recruited or consented for inclusion in these data. Cohort participants may therefore also be represented within the population-level administrative data by virtue of residing within an intervention region, but the datasets are not linked at the individual level.

Allocation is non-random. Intervention regions were selected in partnership with health networks based on regional needs assessments, existing relationships and implementation infrastructure, and population-level indicators of chronic pain-related healthcare utilisation. Comparator regions were selected a priori from geographically distinct areas within the same states based on similarity in population characteristics, rurality/remoteness, health-service context and relevant pre-intervention outcome patterns.
Intervention code [1] 334789 0
Treatment: Other
Intervention code [2] 334790 0
Prevention
Intervention code [3] 334791 0
Behaviour
Description of the comparator or control
Concurrent comparator regions receive usual care, with no planned EQUiPP intervention activities during the study period. Comparator regions do not receive the Local Pain Educator Program, the Rethink Pain community campaign or associated implementation strategies. Population-level administrative outcome data are collected for comparator regions over the same calendar periods as intervention regions, comprising an 18-month pre-intervention period, the four-year intervention period, and an 18-month post-intervention period, to account for secular trends, seasonal variation, and other external influences.
Control group
Active

Outcomes
Primary outcome [1] 346279 0
Population-level volume of opioids dispensed to adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [1] 346279 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Primary outcome [2] 347007 0
Population-level volume of pregabalin dispensed to adults (18+ years) residing in the intervention and comparator regions.
Timepoint [2] 347007 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [1] 465300 0
Population-level utilisation of Medicare-subsidised primary healthcare services delivered by AHPRA-registered healthcare professionals (including general practitioners, nurses, and allied health professionals) by adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [1] 465300 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [2] 465301 0
Population-level rates of public hospital emergency department (ED) presentations with a principal diagnosis of chronic pain among adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [2] 465301 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up. Interrupted time series (ITS) analyses will evaluate changes in the level and trend of emergency department presentations following intervention implementation, relative to pre-intervention trajectories and concurrent comparator regions.
Secondary outcome [3] 465305 0
Population-level rates of public hospital inpatient admissions with a principal diagnosis of chronic pain among adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [3] 465305 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [4] 466173 0
Population-level utilisation of Medicare-subsidised musculoskeletal imaging, assessed as a composite measure, comprising X-ray, computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound by adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [4] 466173 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [5] 466501 0
Population-level rates of lumbar spinal fusion among adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [5] 466501 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [6] 466502 0
Population-level rates of lumbar spinal decompression among adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [6] 466502 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [7] 466503 0
Population-level rates of total knee replacement among adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [7] 466503 0
Data will be collected monthly throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [8] 466504 0
Population-level workdays lost associated with chronic pain (including musculoskeletal conditions of more than three months' duration) among adults (18+ years) residing in the intervention and comparator health networks.
Timepoint [8] 466504 0
Data will be collected longitudinally throughout the 84-month study period, comprising: an 18-month pre-intervention baseline, a 48-month intervention period, and an 18-month post-intervention follow-up.
Secondary outcome [9] 466505 0
Self-reported exposure to the EQUiPP community pain literacy campaign among adults residing in participating intervention communities.
Timepoint [9] 466505 0
One-off assessment approximately 6–12 months following launch of the community pain literacy campaign.
Secondary outcome [10] 466506 0
Self-reported perceived influence of the EQUiPP community pain literacy campaign on opioid or pregabalin use (as a composite measure).
Timepoint [10] 466506 0
One-off assessment approximately 6–12 months following launch of the community pain literacy campaign.
Secondary outcome [11] 466513 0
Self-reported intentions to adopt evidence-informed behaviours related to chronic pain management.
Timepoint [11] 466513 0
One-off assessment approximately 6–12 months following launch of the community pain literacy campaign.
Secondary outcome [12] 466514 0
Work or school days lost due to chronic pain.
Timepoint [12] 466514 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [13] 466516 0
Healthcare utilisation
Timepoint [13] 466516 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [14] 466517 0
Medication use
Timepoint [14] 466517 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [15] 466518 0
Pain self-efficacy
Timepoint [15] 466518 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [16] 466525 0
Pain catastrophising
Timepoint [16] 466525 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [17] 466526 0
Fear avoidance
Timepoint [17] 466526 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [18] 466527 0
Social participation
Timepoint [18] 466527 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [19] 466529 0
Health-related quality of life
Timepoint [19] 466529 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [20] 466530 0
Physical function
Timepoint [20] 466530 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [21] 466531 0
Pain-related knowledge
Timepoint [21] 466531 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [22] 466532 0
Pain intensity
Timepoint [22] 466532 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [23] 466533 0
Fatigue
Timepoint [23] 466533 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [24] 466534 0
Depression
Timepoint [24] 466534 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [25] 466535 0
Anxiety
Timepoint [25] 466535 0
Baseline, 6 months, 12 months and 18 months (relative to the commencement of the community pain literacy campaign).
Secondary outcome [26] 466538 0
Experiences and perceptions of the EQUiPP intervention, including campaign exposure, perceived impacts, implementation experiences, contextual influences and perceived pathways of change.
Timepoint [26] 466538 0
6-12 months after commencement of the community pain literacy campaign.
Secondary outcome [27] 466542 0
Reach of the EQUiPP intervention within participating communities and healthcare settings.
Timepoint [27] 466542 0
Cumulative data will be assessed at the conclusion of the intervention delivery.
Secondary outcome [28] 466544 0
Adoption of the EQUiPP intervention by participating healthcare professionals, organisations and community settings.
Timepoint [28] 466544 0
Assessed throughout intervention delivery, and with cumulative data assessed at 18 months, upon conclusion of intervention delivery.
Secondary outcome [29] 466545 0
Implementation of the EQUiPP intervention, including fidelity to core intervention components and adaptations made during delivery.
Timepoint [29] 466545 0
Cumulative data will be assessed at the conclusion of the intervention delivery.
Secondary outcome [30] 466546 0
Maintenance and sustainability of EQUiPP intervention activities within participating communities, healthcare settings and organisations, assessed together as a combined implementation outcome.
Timepoint [30] 466546 0
Assessed during intervention delivery, with cumulative data assessed at 18 months, upon conclusion of intervention delivery.
Secondary outcome [31] 466547 0
Costs and benefits associated with implementation of the EQUiPP intervention, assessed as a composite measure incorporating health system and societal perspectives.
Timepoint [31] 466547 0
Cumulative intervention costs and benefits data will be assessed at the conclusion of the study.

Eligibility
Key inclusion criteria
The EQUiPP study includes several participant groups, each with specific eligibility criteria according to their role in intervention delivery or evaluation.

Population-level administrative data
- Adults aged 18 years and over residing within the intervention or comparator health networks during the study period.

Local Pain Educators
- Registered Australian Health Practitioner Regulation Agency (AHPRA) healthcare professionals practising within participating intervention regions.
- Willing to undertake the Pain Revolution Local Pain Educator Program and associated mentoring.

Co-design participants
- Aged 18 years or older.
- Live or work within one of the seven participating intervention towns or surrounding districts.
- Community member, healthcare professional or someone with an interest in chronic pain.
- Able to read and understand English.
- Willing and able to provide informed consent.

Cross-sectional cohort
- Adults aged 18 years or older.
- Resident of one of the intervention towns or surrounding districts.
- Able to complete a smartphone-based survey in English.

Longitudinal cohort
- Adults aged 18 years or older.
- Self-reported chronic pain (>3 months duration).
- Resident of one of the intervention towns or surrounding districts.
- Able to complete online questionnaires in English.
- Willing to provide informed consent and participate in longitudinal follow-up.

Qualitative interview cohort
- Adults aged 18 years or older.
- A longitudinal cohort participant or EQUiPP project interest-holder (e.g., healthcare professional, partner organisation representative or community member) who has interacted with, used or seen the community pain literacy campaign.
- Live or work within one of the seven participating intervention towns or surrounding districts.
- Able to participate in an interview in English.
- Willing and able to provide informed consent.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Population administrative datasets
- Individuals younger than 18 years.

Local Pain Educators
- Healthcare professionals not AHPRA registered or practising within participating intervention regions.
- Unable to complete required Local Pain Educator training.

Co-design participants
- Younger than 18 years.
- Unable to provide informed consent.
- Insufficient English proficiency to complete study procedures.
- Not residing (or, for co-design participants, not living or working) within participating intervention communities.

Cross-sectional cohort
- Aged younger than 18 years.
- Unable to provide informed consent.
- Insufficient English proficiency to complete study procedures.
- Not residing within one of the participating intervention communities.

Longitudinal cohort
- Aged younger than 18 years.
- Unable to provide informed consent.
- Insufficient English proficiency to complete study procedures.
- Does not report chronic pain of at least three months’ duration.
- Not residing within one of the participating intervention communities.

Qualitative interview cohort
- Aged younger than 18 years.
- Unable to provide informed consent.
- Insufficient English proficiency to participate in an interview.
- Neither a longitudinal cohort participant nor an EQUiPP project interest-holder (e.g., healthcare professional, partner organisation representative or community member).
- Has not interacted with, used or seen the community pain literacy campaign.
- Does not live or work within one of the participating intervention towns or surrounding districts.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Intervention is determined by geographic health network. Two rural and regional health networks receive the intervention and are compared with two concurrent comparator health networks receiving usual care.
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Population-level outcomes will be analysed using segmented interrupted time series regression with concurrent comparator regions. Models will estimate changes in outcome level and trend following intervention implementation while adjusting for secular trends and regional variation. Sensitivity analyses will explore lagged intervention effects and alternative autocorrelation structures.

Cross-sectional and longitudinal cohort data will be analysed using descriptive statistics, regression analyses and linear mixed-effects models as appropriate. Qualitative interview cohort data will undergo thematic analysis. Economic evaluation will comprise cost-benefit analyses from health system and societal perspectives.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA,VIC

Funding & Sponsors
Funding source category [1] 322454 0
Government body
Name [1] 322454 0
Australian Department of Health, Disability and Ageing, Medical Research Future Fund (MRFF)
Country [1] 322454 0
Australia
Primary sponsor type
Individual
Name
Professor Lorimer Moseley AO (Adelaide University)
Address
Country
Australia
Secondary sponsor category [1] 326057 0
None
Name [1] 326057 0
Address [1] 326057 0
Country [1] 326057 0
Other collaborator category [1] 284107 0
Government body
Name [1] 284107 0
Office of the Commissioner for Public Sector Employment
Address [1] 284107 0
Country [1] 284107 0
Australia
Other collaborator category [2] 284108 0
Commercial sector/Industry
Name [2] 284108 0
Lawson Risk Management Services
Address [2] 284108 0
Country [2] 284108 0
Australia
Other collaborator category [3] 284109 0
Government body
Name [3] 284109 0
Western Victoria Primary Health Network
Address [3] 284109 0
Country [3] 284109 0
Australia
Other collaborator category [4] 284110 0
Government body
Name [4] 284110 0
Commission on Excellence and Innovation in Health
Address [4] 284110 0
Country [4] 284110 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320945 0
University of South Australia Human Research Ethics Committee
Ethics committee address [1] 320945 0
Ethics committee country [1] 320945 0
Australia
Date submitted for ethics approval [1] 320945 0
20/06/2024
Approval date [1] 320945 0
14/08/2024
Ethics approval number [1] 320945 0
206208
Ethics committee name [2] 321077 0
University of South Australia Human Research Ethics Committee
Ethics committee address [2] 321077 0
Ethics committee country [2] 321077 0
Australia
Date submitted for ethics approval [2] 321077 0
05/11/2024
Approval date [2] 321077 0
06/01/2025
Ethics approval number [2] 321077 0
206677
Ethics committee name [3] 321078 0
University of South Australia Human Research Ethics Committee
Ethics committee address [3] 321078 0
Ethics committee country [3] 321078 0
Australia
Date submitted for ethics approval [3] 321078 0
28/10/2025
Approval date [3] 321078 0
01/12/2025
Ethics approval number [3] 321078 0
207430

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152162 0
Prof Lorimer Moseley
Address 152162 0
Adelaide University: GPO Box 2471, Adelaide SA 5001
Country 152162 0
Australia
Phone 152162 0
+61 8 83022454
Fax 152162 0
Email 152162 0
Contact person for public queries
Name 152163 0
Louise Wiles
Address 152163 0
Adelaide University: GPO Box 2471, Adelaide SA 5001
Country 152163 0
Australia
Phone 152163 0
+61 8 83022152
Fax 152163 0
Email 152163 0
Contact person for scientific queries
Name 152164 0
Lorimer Moseley
Address 152164 0
Adelaide University: GPO Box 2471, Adelaide SA 5001
Country 152164 0
Australia
Phone 152164 0
+61 8 83022454
Fax 152164 0
Email 152164 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: No. Individual participant data will not be shared. Although study data will be de-identified, participants are recruited from a small number of rural and regional communities, increasing the potential risk of re-identification through combinations of demographic and geographic characteristics. Data sharing is also subject to ethics approval, participant consent and data governance requirements. Aggregate study findings will be published and reported in accordance with ethical and institutional requirements.



What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Study protocol    Will be made publicly available via a publicly acc... [More Details]
Statistical analysis plan    Will be made publicly available when finalised, pr... [More Details]


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.